Seguridad del tratamiento con surfactante pulmonar en el síndrome de dificultad respiratoria aguda en adultos

Barrese Pérez, YinetCentro Nacional Coordinador de Ensayos Clínicos; Hidalgo Sánchez, Ángela OlgaCentro Nacional Coordinador de Ensayos Clínicos; Ávila Albuerne, Yisel Centro Nacional Coordinador de Ensayos Clinicos; Uranga Piña, Rolando Centro Nacional Coordinador de Ensayos Clínicos; Díaz Casañas, ElaineCentro Nacional de Sanidad Agropecuaria; Fernández Limia, OctavioCentro Nacional de Sanidad Agropecuaria.
Arch. méd. Camaguey ; 19(6)nov-dic 2015.
Artículo en Español | CUMED | ID: cum-66282

Documentos relacionados

  1. Hospital Variation in Mortality and Ventilator Management among Mechanically Ventilated Patients with ARDS.
  2. Biological Phenotyping in Sepsis and Acute Respiratory Distress Syndrome.
  3. [New 2023 global definition of acute respiratory distress syndrome: progress and limitation].
  4. Acute Respiratory Distress Syndrome in Pregnancy: Updates in Principles and Practice.
  5. Tackling Brain and Muscle Dysfunction in Acute Respiratory Distress Syndrome Survivors: NHLBI Workshop Report.
  6. [Potential of AI for the Treatment of Acute Respiratory Distress Syndrome (ARDS)].
  7. Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes.
  8. A New Global Definition of Acute Respiratory Distress Syndrome.
  9. A systematic review of machine learning models for management, prediction and classification of ARDS.
  10. Pulmonary drug delivery for acute respiratory distress syndrome.